Visual Feedback Goggle for Positional Vertigo Treatment
Primary Purpose
Positional Vertigo, Vertigo
Status
Unknown status
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Goggle with 20 degree error
Optimized Goggle
Sponsored by
About this trial
This is an interventional treatment trial for Positional Vertigo focused on measuring Vertigo, Benign Paroxysmal Positional Vertigo, BPPV, Positional Vertigo
Eligibility Criteria
Inclusion Criteria:
- Age: 30-80
- Old patients (more than one year since first symptom)or new patients(more than 3 months duration of symptoms) diagnosed by physicians with Benign Paroxysmal Positional Vertigo (BPPV)
- Must have good neck flexibility to perform the movements of the Epley maneuver
- Subject is willing and able to provide written informed consent
- Subject is willing to remain in the clinic for the treatment and follow-up visits
Exclusion Criteria:
- Age < 30 or Age > 80
- Can not perform the movements of the Epley maneuver
- No informed consent form
- Not willing to remain in the clinic for the treatment and follow-up visits
Sites / Locations
- Jay Farrior, MD
- Debra Cooke, PH.D.
- Mitchell Schwaber, MD
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
1 Goggle I
2 Google II
Arm Description
Optimized Goggle
Goggle with 20 Degree error
Outcomes
Primary Outcome Measures
Symptom Relief Speed (SRS): defined as the number of days post-treatment until dizziness symptoms improve to category 5 (70-100% improvement from baseline).
Symptom Relief Completeness (SRC): defined as the highest level (on the ordinal scale) of improvement attained during the allotted seven-day time period.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00729885
Brief Title
Visual Feedback Goggle for Positional Vertigo Treatment
Official Title
Visual Feedback Goggle For The Treatment Of Benign Paroxysmal Positional Vertigo in a Randomized Single-Blind Study
Study Type
Interventional
2. Study Status
Record Verification Date
August 2008
Overall Recruitment Status
Unknown status
Study Start Date
November 2006 (undefined)
Primary Completion Date
August 2008 (Anticipated)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Vertigone Inc.
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Benign Paroxysmal Positional Vertigo (BPPV) is one of the most common causes of vertigo and the most common vestibular disorder of the inner ear. BPPV is the result of small free-floating particles (canaliths) in the posterior semicircular canals where they aggravate the sensory apparatus and induce sudden and severe attacks of vertigo when the head is turned into certain positions.
The treatment of BPPV was revolutionized by the introduction of the Epley maneuver, a sequence of head movements that use gravity to reposition the canaliths within the inner ear. The Epley maneuver provides prompt relief from vertigo in approximately 80% of patients.
The innovation, the Vertigone goggle, provides both physician and patient with visual feedback to guide them through an accurate Epley maneuver. This changes the current treatment paradigm for BPPV, greatly increasing the availability of the maneuver to non-specialist physicians, nurse practitioners, physician's assistants and physical therapists. The device is designed so that the patient with recurrent vertigo can use the goggle to treat BPPV at home. The goggle is currently a pre-market prototype.
The hypothesis for the study is that accuracy in the performance of the Epley maneuver correlates with improved clinical resolution of vertigo in BPPV patients. If the hypothesis is true, then there is a clear case for the utility of the visual feedback provided by the VertiGONE goggle in performing the maneuver.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Positional Vertigo, Vertigo
Keywords
Vertigo, Benign Paroxysmal Positional Vertigo, BPPV, Positional Vertigo
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
1 Goggle I
Arm Type
Experimental
Arm Description
Optimized Goggle
Arm Title
2 Google II
Arm Type
Sham Comparator
Arm Description
Goggle with 20 Degree error
Intervention Type
Device
Intervention Name(s)
Goggle with 20 degree error
Intervention Description
The Vertigone Goggle is modified such that the head positions and visual feedback indicators are offset 20° from the classic Epley positions.
Intervention Type
Device
Intervention Name(s)
Optimized Goggle
Intervention Description
The classic Epley maneuver involves 3 head positions: 1) the patient supine, the neck is extended 20°and the head turned 45° towards the affected ear, 2) the patient rotates his head 90° to the contralateral side, with the final head position 45° from vertical, 3) the patient turns his head 135° towards the floor on the contralateral side. For the classic Epley maneuver, the goggle coach ball markings will be set for correct positioning.
Primary Outcome Measure Information:
Title
Symptom Relief Speed (SRS): defined as the number of days post-treatment until dizziness symptoms improve to category 5 (70-100% improvement from baseline).
Time Frame
This endpoint will be measured twice: once following the baseline visit and again following the subsequent visit and treatment.
Title
Symptom Relief Completeness (SRC): defined as the highest level (on the ordinal scale) of improvement attained during the allotted seven-day time period.
Time Frame
This endpoint will also be measured twice, in the same manner as was SRS.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age: 30-80
Old patients (more than one year since first symptom)or new patients(more than 3 months duration of symptoms) diagnosed by physicians with Benign Paroxysmal Positional Vertigo (BPPV)
Must have good neck flexibility to perform the movements of the Epley maneuver
Subject is willing and able to provide written informed consent
Subject is willing to remain in the clinic for the treatment and follow-up visits
Exclusion Criteria:
Age < 30 or Age > 80
Can not perform the movements of the Epley maneuver
No informed consent form
Not willing to remain in the clinic for the treatment and follow-up visits
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Philip F Anthony, MD
Organizational Affiliation
Vertigone Inc.
Official's Role
Principal Investigator
Facility Information:
Facility Name
Jay Farrior, MD
City
Tampa
State/Province
Florida
Country
United States
Facility Name
Debra Cooke, PH.D.
City
Kansas City
State/Province
Missouri
Country
United States
Facility Name
Mitchell Schwaber, MD
City
Nashville
State/Province
Tennessee
Country
United States
12. IPD Sharing Statement
Links:
URL
http://www.vertigone.com
Description
Vertigone, Inc. 901 Hemphill Street, Fort Worth, Texas 76104
Learn more about this trial
Visual Feedback Goggle for Positional Vertigo Treatment
We'll reach out to this number within 24 hrs